Is Genetic Technologies Limited (GENE) Stock Worth a Buy Wednesday?

Wednesday, July 15, 2020 9:48 AM | InvestorsObserver Analysts

Genetic Technologies Limited (GENE) stock is higher by 31.25% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives GENE stock a score of 25 out of a possible 100.

That rank is mainly influenced by a fundamental score of 0. . GENE's rank also includes a long-term technical score of 34. The short-term technical score for GENE is 40.

Overall Score - 25
GENE has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on GENE!

What's Happening with GENE Stock Today

Genetic Technologies Limited (GENE) stock is higher by 48.67% while the S&P 500 is higher by 0.83% as of 9:40 AM on Wednesday, Jul 15. GENE is higher by $1.10 from the previous closing price of $2.26 on volume of 4,366,056 shares. Over the past year the S&P 500 is higher by 7.32% while GENE is higher by 31.25%. GENE lost -$0.45 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Genetic Technologies Limited (GENE) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Related Companies